Adalimumab biosimiliar(Kidswell Bio)

N/A

Report date: 2024/02/06 15:03:37

Base Information

Drug NameAdalimumab biosimiliar(Kidswell Bio)

Drug Alias NameGBS005GBS-005

ClassificationBiologics > Biosimilar

Mechanisms of ActionTumor necrosis factor α inhibitors

TargetsTumor necrosis factor α

Therapy Area/IndicationsImmune System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKidswell Bio Corp

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsImmune System Diseases

Inactive IndicationsN/A

ATC CodeL04AB04